The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Patients with Long-Term Oral Carriage Harbor High-Persister Mutants of Candida albicans
Open accessAbstract
Fungal biofilms produce a small number of persister cells which can tolerate high concentrations of fungicidal agents. Persisters form upon attachment to a surface, an important step in the pathogenesis of Candida strains. The periodic application of antimicrobial agents may select for strains with increased levels of persister cells. In order to test this possibility, 150 isolates of Candida albicans and C. glabrata were obtained from cancer patients who were at high risk for the development of oral candidiasis and who had been treated with topical chlorhexidine once a day. Persister levels were measured by exposing biofilms growing in the wells of microtiter plates to high concentrations of amphotericin B and plating for survivors. The persister levels of the isolates varied from 0.2 to 9%, and strains isolated from patients with long-term carriage had high levels of persisters. High-persister strains were isolated from every patient with Candida carriage of more than 8 consecutive weeks but from no patients with transient carriage. All of the high-persister isolates had an amphotericin B MIC that was the same as that for the wild type, indicating that these strains were drug-tolerant rather than drug-resistant mutants. Biofilms of the majority of high-persister strains also showed an increased tolerance to chlorhexidine and had the same MIC for this antimicrobial as the wild type. This study suggests that persister cells are clinically relevant, and antimicrobial therapy selects for high-persister strains in vivo. The drug tolerance of persisters may be a critical but overlooked component responsible for antimicrobial drug failure and relapsing infections.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“LaFleur and colleagues reported that isolates from cancer patients with long-term C. albicans oral colonization displayed significantly higher levels of persistence compared to those from short-term carriers [13].”
From Antifungal persistence: Clinical relevance and mechanisms (2025) · cites this paper as [13]
Citations
Cites
Persister cells, dormancy and infectious disease
Lewis, K. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1557 · Cited by 2,052
Self-citationIsogenic strain construction and gene mapping in Candida albicans.
Fonzi, W. A., & Irwin, M. Y. (1993) · Genetics · doi:10.1093/genetics/134.3.717 · Cited by 1,695
Candida biofilms and their role in infection
Douglas, L. J. (2003) · Trends in Microbiology · doi:10.1016/s0966-842x(02)00002-1 · Cited by 1,150
Spoering, A. L., & Lewis, K. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.23.6746-6751.2001 · Cited by 907
Self-citationSpecialized Persister Cells and the Mechanism of Multidrug Tolerance in Escherichia coli
Keren, I., Shah, D., Spoering, A. L., Kaldalu, N., & Lewis, K. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.24.8172-8180.2004 · Cited by 848
Self-citationStandardized Method for In Vitro Antifungal Susceptibility Testing of Candida albicans Biofilms
Ramage, G., Vande Walle, K., Wickes, B. L., & López-Ribot, J. L. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.9.2475-2479.2001 · Cited by 753
Moyed, H. S., & Bertrand, K. P. (1983) · Journal of Bacteriology · doi:10.1128/jb.155.2.768-775.1983 · Cited by 641
Odds, F. C., & Bernaerts, R. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.8.1923-1929.1994 · Cited by 631
Persisters: a distinct physiological state of E. coli
Khodursky, A. B., Zhang, Z., Devang, S., Kaldalu, N., Kurg, K., & Lewis, K. (2006) · Digital Repository Service (Northeastern University) · doi:10.1186/1471-2180-6-53 · Cited by 630
Self-citationPersister cells and the riddle of biofilm survival
Lewis, K. (2005) · Biochemistry (Moscow) · doi:10.1007/s10541-005-0111-6 · Cited by 524
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- Ghannoum, M. A., and S. S. Radwan. 1990. The adherence process, p. 106-154. InCandida adherence to epithelial cells. CRC Press, Boca Raton, FL.
Cited by
Sorted by citations
Items 101–200 of 235
Groote, V. N. D., Fauvart, M., Kint, C. I., Verstraeten, N., Jans, A., Cornélis, P., & Michiels, J. J. (2011) · Journal of Medical Microbiology · doi:10.1099/jmm.0.019703-0 · Cited by 39
Pan, J., Xie, X., Wang, T., Bahar, A. A., Lin, N., Song, F., An, J., & Ren, D. (2013) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-013-5185-2 · Cited by 37
Maeda, T., & Furusawa, C. (2024) · Antibiotics · doi:10.3390/antibiotics13010094 · Cited by 43
Kaneko, Y., Miyagawa, S., Takeda, O., Hakariya, M., Matsumoto, S., Ohno, H., & Miyazaki, Y. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02290-12 · Cited by 36
Potentiation of Azole Antifungals by 2-Adamantanamine
LaFleur, M. D., Sun, L., Lister, I., Keating, J., Nantel, A., Long, L. A., Ghannoum, M. A., North, J., Lee, R. E., Jr., Coleman, K., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00294-13 · Cited by 35
Self-citationFormation of persisters in Streptococcus mutans biofilms induced by antibacterial dental monomer
Wang, S., Zhou, C., Ren, B., Li, X., Weir, M. D., Masri, R. M., Oates, T. W., Cheng, L., & Xu, H. H. K. (2017) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-017-5981-9 · Cited by 35
Persistence and drug tolerance in pathogenic yeast
Bojsen, R. K., Regenberg, B., & Folkesson, A. (2016) · Current Genetics · doi:10.1007/s00294-016-0613-3 · Cited by 33
Persisters: Methods for Isolation and Identifying Contributing Factors—A Review
Rowe, S. E., Conlon, B. P., Keren, I., & Lewis, K. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2854-5_2 · Cited by 35
Self-citationTrichosporon asahii and Trichosporon inkin biofilms produce antifungal-tolerant persister cells
Cordeiro, R. D. A., Aguiar, A. L. R., da Silva, B. N., Pereira, L. M. G., Portela, F. V. M., de Camargo, Z. P., de Lima-Neto, R. G., Castelo-Branco, D. D. S. C. M., Rocha, M. F. G., & Sidrim, J. J. C. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.645812 · Cited by 34
Jiang, Y., Qiu, W., Zhou, X., Li, H., Lu, J., Xu, H. H. K., Peng, X., Li, M., Feng, M., Cheng, L., et al. (2017) · International Journal of Oral Science · doi:10.1038/ijos.2017.46 · Cited by 33
Mattiello, S. P., Gallo, S. W., Ferreira, P. M. A., Ferreira, C. A. S., & de Oliveira, S. D. (2019) · Scientific Reports · doi:10.1038/s41598-019-43631-7 · Cited by 31
Candida albicans Biofilms Are Generally Devoid of Persister Cells
Denega, I., d’Enfert, C., & Bachellier-Bassi, S. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01979-18 · Cited by 32
Candida albicans amphotericin B-tolerant persister formation is closely related to surface adhesion
Sun, J., Li, Z., Chu, H., Guo, J., Jiang, G., & Qi, Q. (2016) · Mycopathologia · doi:10.1007/s11046-015-9894-1 · Cited by 32
Self-citationmsaABCR operon is involved in persister cell formation in Staphylococcus aureus
Sahukhal, G. S., Pandey, S., & Elasri, M. O. (2017) · BMC Microbiology · doi:10.1186/s12866-017-1129-9 · Cited by 31
Mo, F., Ma, J., Yang, X., Zhang, P., Li, Q., & Zhang, J. (2020) · Phytomedicine · doi:10.1016/j.phymed.2020.153223 · Cited by 31
Combinatorial drug approaches to tackleCandida albicansbiofilms
Cremer, K. D., Staes, I., Delattin, N., Cammue, B. P. A., Thevissen, K., & Brucker, K. D. (2015) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2015.1056162 · Cited by 31
Persister Eradication: Lessons from the World of Natural Products
Keren, I., Mulcahy, L. R., & Lewis, K. (2012) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-404634-4.00019-x · Cited by 32
Self-citationWilmaerts, D., Focant, C., Matthay, P., & Michiels, J. J. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110427 · Cited by 32
Xie, C., Sun, L., Meng, L., Wang, M., Xu, J., Bartlam, M. G., & Guo, Y. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.09.013 · Cited by 28
Liebens, V., Defraine, V., der Leyden, A. V., Groote, V. N. D., Fierro, C., Beullens, S., Verstraeten, N., Kint, C. I., Jans, A., Frangipani, E., et al. (2014) · Pathogens and Disease · doi:10.1111/2049-632x.12174 · Cited by 29
A survey of within-host and between-hosts modelling for antibiotic resistance
Tetteh, J. N. A., Matthäus, F., & Hernandez-Vargas, E. A. (2020) · Biosystems · doi:10.1016/j.biosystems.2020.104182 · Cited by 29
Oxidative imbalance in Candida tropicalis biofilms and its relation with persister cells
da Silva, M. A., Baronetti, J. L., Páez, P. L., & Paraje, M. G. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.598834 · Cited by 28
Theis, T. J., Daubert, T., Kluthe, K. E., Brodd, K. L., & Nuxoll, A. S. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1178526 · Cited by 30
Future therapies targeted towards eliminatingCandidabiofilms and associated infections
Bandara, N., Matsubara, V. H., & Samaranayake, L. P. (2016) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2017.1268530 · Cited by 29
Priya, A., Nivetha, S., & Pandian, S. K. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.780545 · Cited by 29
Antipersister strategies against stress induced bacterial persistence
Kaushik, V., Sharma, S., Tiwari, M., & Tiwari, V. (2022) · Microbial Pathogenesis · doi:10.1016/j.micpath.2022.105423 · Cited by 27
Molecular mechanism and application of emerging technologies in study of bacterial persisters
Yuan, S., Shen, Y., Quan, Y., Gao, S., Zuo, J., Jin, W., Li, R., Yi, L., Wang, Y., & Wang, Y. (2024) · BMC Microbiology · doi:10.1186/s12866-024-03628-3 · Cited by 31
A Historical Perspective on Bacterial Persistence
Verstraeten, N., Knapen, W., Fauvart, M., & Michiels, J. J. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2854-5_1 · Cited by 26
Mixed Fungal Biofilms: From Mycobiota to Devices, a New Challenge on Clinical Practice
Costa, P. D. S., Prado, A., Bagon, N. P., Negri, M., & Svidzinski, T. I. E. (2022) · Microorganisms · doi:10.3390/microorganisms10091721 · Cited by 25
Maxwell, C. S., & Magwene, P. M. (2017) · Evolution · doi:10.1111/evo.13199 · Cited by 23
Potentiation of Antibiofilm Activity of Amphotericin B by Superoxide Dismutase Inhibition
Brucker, K. D., Bink, A., Meert, E. M. K., Cammue, B. P. A., & Thevissen, K. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/704654 · Cited by 24
Wu, X., Zhang, S., Xu, X., Shen, L., Xu, B., Qu, W., Zhuang, W., Locock, K., Deighton, M., & Qu, Y. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02592 · Cited by 23
Type I toxin-antitoxin systems in bacteria: from regulation to biological functions
Shore, S. F. H., Leinberger, F. H., Fozo, E. M., & Berghoff, B. A. (2024) · EcoSal Plus · doi:10.1128/ecosalplus.esp-0025-2022 · Cited by 26
Pandey, S., Sahukhal, G. S., & Elasri, M. O. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.657753 · Cited by 22
El Meouche, I., Jain, P., Jolly, M. K., & Capp, J.-P. (2024) · Translational Oncology · doi:10.1016/j.tranon.2024.102069 · Cited by 22
Identification of type II toxin-antitoxin modules inBurkholderia pseudomallei
Butt, A. T., Müller, C., Harmer, N. J., & Titball, R. W. (2012) · FEMS Microbiology Letters · doi:10.1111/1574-6968.12032 · Cited by 22
Pani, S., & Mohapatra, S. S. (2024) · Archives of Microbiology · doi:10.1007/s00203-024-04173-3 · Cited by 23
Aedo, S. J., Orman, M. A., & Brynildsen, M. P. (2019) · BMC Microbiology · doi:10.1186/s12866-019-1506-7 · Cited by 20
Anuța, V., Talianu, M.-T., Dinu‐Pîrvu, C., Ghica, M. V., Prisada, R. M., Kaya, M. G. A., & Popa, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147520 · Cited by 22
Priestia megaterium cells are primed for surviving lethal doses of antibiotics and chemical stress
Guha, M., Singh, A., & Butzin, N. C. (2025) · Communications Biology · doi:10.1038/s42003-025-07639-2 · Cited by 25
Černáková, L., Líšková, A., Lengyelová, L., & Rodrigues, C. F. (2022) · Medicina · doi:10.3390/medicina58050576 · Cited by 20
Gattu, R., Ramesh, S. S., & Ramesh, S. (2024) · Microbial Pathogenesis · doi:10.1016/j.micpath.2024.106543 · Cited by 19
Molecular Principles of Adhesion and Biofilm Formation
Kreth, J., & Herzberg, M. C. (2015) · Springer series on biofilms · doi:10.1007/978-3-662-47415-0_2 · Cited by 20
van Tatenhove‐Pel, R. J., Zwering, E., Solopova, A., Kuipers, O. P., & Bachmann, H. (2019) · Scientific Reports · doi:10.1038/s41598-019-46344-z · Cited by 18
Lu, J., Cheng, L., Huang, Y., Jiang, Y., Chu, C.-H., Peng, X., Li, M., Xu, H. H. K., Zhou, X., & Ren, B. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.03102 · Cited by 18
Chromatin Structure and Drug Resistance in Candida spp.
O’Kane, C. J., Weild, R., & Hyland, E. M. (2020) · Journal of Fungi · doi:10.3390/jof6030121 · Cited by 19
Liebens, V., Defraine, V., Knapen, W., Swings, T., Beullens, S., Corbau, R., Marchand, A., Chaltin, P., Fauvart, M., & Michiels, J. J. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00836-17 · Cited by 18
Lotfali, E., Fattahi, A., Sayyahfar, S., Ghasemi, R., Rabiei, M. M., Fathi, M., Vakili, K. G., Deravi, N., Soheili, A., Toreyhi, H., et al. (2021) · Microbial Drug Resistance · doi:10.1089/mdr.2020.0235 · Cited by 18
Persister Cells and the Paradox of Chronic Infections
Lewis, K. (2010) · Microbe Magazine · doi:10.1128/microbe.5.429.1 · Cited by 17
Self-citationUnrelated toxin–antitoxin systems cooperate to induce persistence
Fasani, R. A., & Savageau, M. A. (2015) · Journal of The Royal Society Interface · doi:10.1098/rsif.2015.0130 · Cited by 16
Novel treatment dynamics for biofilm-related infections
del Pozo, J. L. (2021) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2021.1917993 · Cited by 19
From IBS to ME – The dysbiotic march hypothesis
Berstad, A., Hauso, O., Berstad, K., & Berstad, J. R. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.109648 · Cited by 15
Disentangling Direct and Indirect Fitness Effects of Microbial Dormancy
Ratcliff, W. C., Hoverman, M., Travisano, M., & Denison, R. F. (2013) · The American Naturalist · doi:10.1086/670943 · Cited by 14
Lemma, A. S., & Brynildsen, M. P. (2021) · mBio · doi:10.1128/mbio.01983-21 · Cited by 15
Wang, C., Li, X., Cheng, T., Sun, H., & Jin, L. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.748121 · Cited by 15
Protocol for Determination of the Persister Subpopulation in Candida Albicans Biofilms
Brucker, K. D., Cremer, K. D., Cammue, B. P. A., & Thevissen, K. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2854-5_6 · Cited by 15
Nanoarchitectonics Used in Antiinfective Therapy
Grumezescu, A. M., Holban, A. M., Barbu, I. C., Popescu, R. C., Oprea, A. E., Lazăr, V., Grumezescu, A. M., & Chifiriuc, M. C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803642-6.00007-1 · Cited by 14
Alruwaili, Y. S., Jacobs, M. B., Hasenkampf, N. R., Tardo, A. C., McDaniel, C. E., & Embers, M. E. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1293300 · Cited by 14
Kampf, G. (2018) · Springer eBooks · doi:10.1007/978-3-319-98785-9_13 · Cited by 13
Hodzic, E., Imai, D. M., & Escobar, E. (2019) · Infection and Immunity · doi:10.1128/iai.00442-19 · Cited by 13
Liu, L., Wang, Y., Bojer, M. S., Andersen, P. S., & Ingmer, H. (2020) · Microbiology · doi:10.1099/mic.0.000926 · Cited by 12
Dynamic Boolean modelling reveals the influence of energy supply on bacterial efflux pump expression
Kerr, R., Jabbari, S., Blair, J. M. A., & Johnston, I. G. (2022) · Journal of The Royal Society Interface · doi:10.1098/rsif.2021.0771 · Cited by 10
Bugs on Drugs: A Drosophila melanogaster Gut Model to Study In Vivo Antibiotic Tolerance of E. coli
den Bergh, B. V. (2022) · Microorganisms · doi:10.3390/microorganisms10010119 · Cited by 13
Aboualigalehdari, E., Tahmasebi Birgani, M., Fatahinia, M., & Hosseinzadeh, M. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.651221 · Cited by 11
Beyond metabolic dormancy: metabolic rewiring in bacterial persistence
Orman, M. A., Ngo, H. G., & Mohiuddin, S. G. (2026) · Nature Communications · doi:10.1038/s41467-026-71427-7 · Cited by 13
Radiometal chelators for infection diagnostics
Akter, A., Lyons, O., Mehra, V., Isenman, H. L., & Abbate, V. (2023) · Frontiers in Nuclear Medicine · doi:10.3389/fnume.2022.1058388 · Cited by 11
Witzany, C., Regoes, R. R., & Igler, C. (2022) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2022.1300 · Cited by 10
Lagree, K., & Mitchell, A. P. (2017) · ASM Press eBooks · doi:10.1128/9781555819583.ch42 · Cited by 9
Experimental Evolution of Escherichia coli Persister Levels Using Cyclic Antibiotic Treatments
den Bergh, B. V., Michiels, J. E., & Michiels, J. J. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2854-5_12 · Cited by 10
Tolerance and Persister Formation in Oral Streptococci
Suppiger, S., Astasov‐Frauenhoffer, M., Schweizer, I., Waltimo, T. M. T., & Kulik, E. M. (2020) · Antibiotics · doi:10.3390/antibiotics9040167 · Cited by 10
Persister cells in human fungal pathogens
Xie, Y., Ke, W., Wong, K. H., & Wang, L. (2025) · PLoS Pathogens · doi:10.1371/journal.ppat.1013483 · Cited by 10
Li, Y., Wood, T. K., Zhang, W., & Li, C. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1127018 · Cited by 9
Antifungal persistence: Clinical relevance and mechanisms
Wang, R., Lv, J., Chen, L., Zhao, Y., & Du, H. (2025) · PLoS pathogens · doi:10.1371/journal.ppat.1013456 · Cited by 12
“LaFleur and colleagues reported that isolates from cancer patients with long-term C. albicans oral colonization displayed significantly higher levels of persistence compared to those from short-term carriers [13].”
González, J. F., Hitt, R., Laipply, B., & Gunn, J. S. (2022) · Microorganisms · doi:10.3390/microorganisms10112276 · Cited by 8
Sinoca, M., Maione, A., Gambino, E., Imparato, M., Galdiero, M., de Alteriis, E., Galdiero, E., & Guida, M. (2024) · Biomedicines · doi:10.3390/biomedicines12020389 · Cited by 7
Liu, Y., Zhang, X., Cheng, H., Li, Y., & Zhou, G. (2023) · Journal of Herbal Medicine · doi:10.1016/j.hermed.2023.100752 · Cited by 7
Candida albicans: a historical overview of investigations into an important human pathogen
Shrivastava, M., & Whiteway, M. S. (2025) · Canadian Journal of Microbiology · doi:10.1139/cjm-2025-0036 · Cited by 7
Pham, H. N., Than, T. D. N., Nguyen, H. A., Vu, D. H., Phung, T. H., & Nguyen, T. K. (2024) · Microbial Drug Resistance · doi:10.1089/mdr.2023.0267 · Cited by 11
Kim, M., & Kim, T. (2024) · Journal of the Korean Wood Science and Technology · doi:10.5658/wood.2024.52.2.145 · Cited by 7
Wang, C., Li, X., Cheng, T., Wang, L., & Jin, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105728 · Cited by 7
Sun, J., Liu, X., Jiang, G., & Qi, Q. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03765-14 · Cited by 6
Self-citationIdentification of genes associated with persistence in Mycobacterium smegmatis
Joshi, H., Kandari, D., Maitra, S. S., Bhatnagar, R., & Banerjee, N. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1302883 · Cited by 6
Candida albicans Biofilms, Heterogeneity and Antifungal Drug Tolerance
LaFleur, M. D. (2011) · The Open Mycology Journal · doi:10.2174/1874437001105010021 · Cited by 6
Self-citationGoudarzi, M., Navidinia, M., Khadembashi, N., & Rasouli, R. (2021) · Archives of Clinical Infectious Diseases · doi:10.5812/archcid.107919 · Cited by 8
Mathé‐Hubert, H., Amia, R., Martin, M., Gaffé, J., & Schneider, D. (2022) · Antibiotics · doi:10.3390/antibiotics11040451 · Cited by 6
How Promising are Combinatorial Drug Strategies in Combating Candida Albicans Biofilms?
Thevissen, K. (2016) · Future Medicinal Chemistry · doi:10.4155/fmc-2016-0127 · Cited by 6
Mojsoska, B., Cameron, D. R., Bartell, J. A., Haagensen, J. A. J., Sommer, L. M., Lewis, K., Molin, S., & Johansen, H. K. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/561589 · Cited by 6
Self-citationYe, M., Chen, H., Liu, C., Ren, A.-J., Yang, H., & Wang, S.-S. (2022) · Journal of Applied Microbiology · doi:10.1111/jam.15718 · Cited by 4
Toxin-Antitoxin Systems and Bacterial Persistence (Review)
Zamakhaev, M. V., Гончаренко, А. В., & Shumkov, M. S. (2019) · Applied Biochemistry and Microbiology · doi:10.1134/s0003683819060140 · Cited by 7
An Introduction to the Biology of Biofilm Recalcitrance
Humphreys, G. J., & McBain, A. J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397043-5.00014-1 · Cited by 5
Targeting Phenotypically TolerantMycobacterium tuberculosis
Gold, B. S., & Nathan, C. (2017) · ASM Press eBooks · doi:10.1128/9781555819569.ch15 · Cited by 5
Studying Bacterial Persistence: Established Methods and Current Advances
Louwagie, E., Verstraete, L., Michiels, J. J., & Verstraeten, N. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1621-5_1 · Cited by 4
The resistance peculiarities of E.coli and C.albicans clinical isolates forming a biofilm
Artsiukh, T. V., Sokolova, T. N., & Astrowskaja, А. B. (2021) · Vestnik of Vitebsk State Medical University · doi:10.22263/2312-4156.2021.1.46 · Cited by 4
Candida Biofilm: Clinical Implications of Recent Advances in Research
Press, E. G., Shields, R. K., & Clancy, C. J. (2014) · Current Fungal Infection Reports · doi:10.1007/s12281-014-0176-z · Cited by 4
Persisters of Bacterial Biofilms
Li, P., & Yao, S. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1009421 · Cited by 3
Host-Fungal Interactions: Pathogenicity versus Immunity
Tavanti, A., Naglik, J. R., & Osherov, N. (2012) · International Journal of Microbiology · doi:10.1155/2012/562480 · Cited by 4
Scully, C. M. (2013) · Elsevier eBooks · doi:10.1016/b978-0-7020-4948-4.00039-8 · Cited by 3
Rogovski, P., Cadamuro, R. D., Souza, D. S. M., de Souza, E. B., da Silva, R., Silva, M. A., Viancelli, A., Michelon, W., Camargo, A. F., Bonatto, C., et al. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822956-9.00003-9 · Cited by 3
Gram-positive bacteria are primed for surviving lethal doses of antibiotics and chemical stressPreprint
Guha, M., Singh, A., & Butzin, N. C. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.28.596288 · Cited by 3
Tsiourvas, D., Sideratou, Z., Mavrogonatou, E., Kletsas, D., Sophianopoulou, V., & Gerostathis, S. (2025) · Scientific Reports · doi:10.1038/s41598-025-11018-6 · Cited by 3
Metadata
- Authors
- LaFleur, M. D., Qi, Q., & Lewis, K.
- Affiliations
- Northeastern University (US)
- Antimicrobial Discovery Center and Department of Biology, Northeastern University, 360 Huntington Avenue, Boston, Massachusetts 02115
- Corresponding author
- Lewis, Kim
- ORCID
- Lewis, Kim
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2010-01
- Volume
- 54
- Issue
- 1
- Pages
- 39-44
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC2798516
- OpenAlex
- W2115712103
- Cited by
- 237
- References
- 32
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 14 · 2023: 9 · 2022: 16 · 2021: 21 · 2020: 18 · 2019: 16 · 2018: 9 · 2017: 15 · 2016: 21 · 2015: 24 · 2014: 12 · 2013: 24 · 2012: 17
- FWCI
- 6.21
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (30400498)
- National Institute of General Medical Sciences (R01GM061162)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Keywords
- Candida albicans, Candida glabrata, persister cells, fungal biofilms, oral candidiasis, drug tolerance, antimicrobial selection, cancer patients, infection relapse
- MeSH terms
- Adult, Aged, Candida albicans, Candidiasis, Carrier State, Chlorhexidine, Dose-Response Relationship, Drug, Female, Genes, Fungal, Humans, Male, Microbial Sensitivity Tests, Middle Aged, Mouth, Mouthwashes, Mutation, Neoplasms, Biofilms, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review